The global infectious
disease diagnostics market is foreseen to grow by 6.2%, from USD 34.26 Billion
in 2021 to USD 55.43 Billion in 2029. Rising technological advancements in
infectious disease diagnostics, shift in focus from centralized laboratories to
decentralized POC testing is to drive the market for the upcoming forecast
period. However, unfavorable reimbursement scenario remains one factor
hindering the market growth over the anticipated period.
What Is Infectious disease
A bacterium, virus, fungus, protozoan, or helminth is
found in a patient with a clinical ailment that is compatible for the diagnosis
of an infectious disease.
infectious disease diagnostics market search study helps to thoroughly
understand the current trend in the market competitive analysis of the players
in the emerging market. Moreover, the DRO in the Infectious disease diagnostics
market offers valuable perspicuity and a current scenario for making the right
decision. The research study covers the eminent players in the market with a
detailed analysis of the company and a financial overview containing their net
sales, business mix and geographical reach It mainly focuses on the key
developments of the products/services offered by the company in recent years.
Besides, we at Zettabyte have the expertise to analyses the global infectious
disease diagnostics market player's competitive landscape helping the client
comprehend their specific strategic growth approaches.
disease diagnostics market study by "Zettabyte Analytics" offers
details about the market scope, market segmentation, technological advancement
in the infectious disease diagnostics market and highlights the optimistic,
competitive landscape and trends enduring over the years.
Major players in
the Infectious disease diagnostics market include Abbott Laboratories, Becton,
Dickinson And Company, Biomérieux Sa, Bio-Rad Laboratories, Inc., Chembio
Diagnostic Systems, Co-Diagnostics, Danaher Corporation, Diasorin S.P.A,
Elitechgroup, Epitope Diagnostics, F. Hoffmann-La Roche Ltd., Genetic
Signatures Ltd., Grifols S.A., Hologic, Inc., Inbios International, Meridian
Bioscience, Meril Lifesciences Pvt. Ltd., Orasure Technologies, Ortho Clinical
Diagnostics Holdings Plc, Perkinelmer, Inc., Qiagen N.V., Quidel Corporation,
Seegene, Inc., Siemens Healthineers Ag, Sysmex Corporation, Thermo Fisher
Scientific Inc., Trinity Biotech Plc, Trivitron Healthcare, Uniogen Oy, Vela
COVID-19 Impact on Global Infectious
Disease Diagnostics Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the Infectious disease
diagnostics market has forced the companies to change their sourcing, pricing,
and promotion strategies. the infectious disease diagnostics market players are
seen focusing more on optimizing the e-commerce networks with the rising
innovations in the digital sector, which are creating new business models for
the healthcare industry player.
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
dynamics, regulatory scenarios, major material dynamics and infectious disease
diagnostics market future markets are analyzed to understand their impact on demand
for the forecast period. growth rates have been estimated using correlation,
regression and time-series analysis.
For the purpose
of this report, the global Infectious disease diagnostics market segmented on
the basis of product type, type of testing, technology, disease type, end-use, and
Product Type Outlook:
On the basis of
product type, the market is segmented into reagents, kits, and consumables,
instruments, software & services.
Type of Testing Outlook:
On the basis of
Type of Testing, the market is segmented into Laboratory Testing, POC Testing.
On the basis of
Technology, the market is segmented into Immunodiagnostics, Clinical
Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other
Figure 1 Infectious Disease Diagnostics Market
By Technology (Market Size And Forecast By Value - USD Million, 2021 & 2029)